These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3572145)

  • 1. [Preclinical and clinical studies of sequential therapy with methotrexate and 5 fluorouracil in breast cancer].
    Kitamura M; Tominaga T; Hayashi K; Takahashi I; Kosaki G
    Nihon Gan Chiryo Gakkai Shi; 1986 Dec; 21(10):2430-8. PubMed ID: 3572145
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current studies of sequential methotrexate and 5-fluorouracil treatment in cancer chemotherapy].
    Murakami M; Ota K
    Gan To Kagaku Ryoho; 1988 Mar; 15(3):409-17. PubMed ID: 3279912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential methotrexate and 5-FU in CMFP (cyclophosphamide, methotrexate, 5-FU, and prednisone) therapy for breast cancer.
    Cadman EC; Glick JH; Cross J; Horton J; Taylor SG
    Cancer Treat Rep; 1984 Jun; 68(6):877-9. PubMed ID: 6547367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical evaluation of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) on advanced and recurrent breast cancer. Clinical study group of CMF for breast cancer in Japan].
    Nomura Y; Tominaga T; Adachi I; Koyama H; Fukami A
    Gan To Kagaku Ryoho; 1994 Sep; 21(12):1949-56. PubMed ID: 8085846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical application of sequential dose methotrexate and 5-FU as a neoadjuvant chemotherapy in advanced stomach carcinoma].
    Urabe T; Akazawa S; Suda Y; Minaguchi S; Yoshida S
    Nihon Gan Chiryo Gakkai Shi; 1986 Oct; 21(9):2284-95. PubMed ID: 3819553
    [No Abstract]   [Full Text] [Related]  

  • 6. Alternating versus sequential therapy in advanced breast cancer.
    Romero A; Rabinovich MG; Pérez JE; Macchiavelli M; Leone BA; Strauss E; Goldar D; Alvarez LA; Vallejo C
    Medicina (B Aires); 1987; 47(3):243-8. PubMed ID: 3326994
    [No Abstract]   [Full Text] [Related]  

  • 7. Sequential methotrexate and 5-FU in breast cancer resistant to the conventional application of these drugs.
    Herrmann R; Manegold C; Schroeder M; Tigges FJ; Bartsch H; Jungi F; Fritze D
    Cancer Treat Rep; 1984 Oct; 68(10):1279-81. PubMed ID: 6525599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental toxicologic and therapeutic studies on the activity of the CMF(cyclophosphamide-methotrexate-5-fluorouracil) scheme versus the VMF(vincristine-methotrexate-5-fluorouracil) scheme].
    Berger MR; Habs M; Schmähl D
    Arch Geschwulstforsch; 1984; 54(4):263-78. PubMed ID: 6548622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Criteria for evaluating the efficacy of treatment of breast cancer metastases to the bones].
    Lichinitser MR; Vyshinskaia GV; Gritsaĭ AA; Kondrat'eva AP; Luk'ianchenko AB
    Med Radiol (Mosk); 1986 Feb; 31(2):28-31. PubMed ID: 3951344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Methotrexate and 5-fluorouracil with leucovorin therapy in advanced gastric cancer: the enhancement of 5-fluorouracil antitumor activity by leucovorin].
    Sugiura I; Ogasawara T; Kinoshita T; Ono Y; Onizuka T; Nagata K; Kamiya O; Ohara K; Hoshino A
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1938-40. PubMed ID: 3496053
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy.
    Chlebowski RT
    J Natl Cancer Inst; 2010 Jan; 102(2):137. PubMed ID: 20019336
    [No Abstract]   [Full Text] [Related]  

  • 12. [5 years' results of a CMF protocol (methotrexate, cyclophosphamide, fluorouracil) of adjuvant chemotherapy in breast cancers].
    Horner-Vallet D; Cappelaere P; Delobelle A; Depadt G; Madelain M; Demaille A
    LARC Med; 1984 Nov; 4(9):532-40. PubMed ID: 6549038
    [No Abstract]   [Full Text] [Related]  

  • 13. Recent progress in breast cancer management. Combined modality (adjuvant) therapy.
    Cowan K; Lippman M
    Arch Intern Med; 1981 Jul; 141(8):1055-9. PubMed ID: 7018440
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical study of ambulatory cancer chemotherapy for recurrent breast cancer].
    Takahashi N; Nitta A; Kunii Y; Ota K
    Gan To Kagaku Ryoho; 1994 Dec; 21 Suppl 4():439-43; discussion 443-4. PubMed ID: 7802447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal schedule of methotrexate and 5-fluorouracil in human breast cancer.
    Benz C; Tillis T; Tattelman E; Cadman E
    Cancer Res; 1982 May; 42(5):2081-6. PubMed ID: 6175406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [CMF or CAF combination chemotherapy for breast cancer].
    Ota J
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1886-90. PubMed ID: 8978791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors.
    Fisher B; Redmond C; Dimitrov NV; Bowman D; Legault-Poisson S; Wickerham DL; Wolmark N; Fisher ER; Margolese R; Sutherland C
    N Engl J Med; 1989 Feb; 320(8):473-8. PubMed ID: 2644531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunomodulating effects of indomethacin in breast cancer].
    Polevaia EB; Chikvashvili BSh; Kupin VI; Letiagin VP
    Sov Med; 1987; (8):27-30. PubMed ID: 3423958
    [No Abstract]   [Full Text] [Related]  

  • 19. [A case of Borrmann type 4 gastric cancer responding to sequential methotrexate and 5-fluorouracil combined with CDDP].
    Nakagohri T; Miyoshi H; Tsunoda Y; Takeuchi H; Hayashi H; Ueda K; Mochizuki R; Miyauchi H; Iwashita R
    Gan To Kagaku Ryoho; 1994 Jan; 21(1):107-10. PubMed ID: 8291905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative evaluation of 2 schedules of administration of anti- neoplastic drugs by the CMF protocol in disseminated breast cancer].
    Korman DB; Snimshchikov VA; Dobroskok LB; Maslova IA; Mikaélian SG; Pines EV
    Sov Med; 1991; (3):14-5. PubMed ID: 1882280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.